Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

391
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

508
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
508
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

380
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
380

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inter-centre heterogeneity, temporal evolution, and factors associated with treatment selection and outcomes in chronic inflammatory demyelinating polyradiculoneuropathy: a multicentre, combined prospective and retrospective observational study.

EClinicalMedicine·2026
Same author

Hemoadsorption in acute pediatric carbamazepine intoxication: a case report and systematic review of extracorporeal therapies.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Risk factors for disease generalization in acetylcholine receptor antibody-positive ocular myasthenia: a multicenter retrospective study.

Frontiers in neurology·2026
Same author

Weight changes and variability in the first week of life: associations with mortality in extremely preterm newborns.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Deep Phenotyping of F64L Mutation in a Multicentric Cohort of Patisiran-Treated Hereditary Transthyretin Amyloidosis Patients (Patisiranitaly).

European journal of neurology·2026
Same author

Salivary Bicarbonate Fails to Mirror Systemic Acid-Base Balance in Pediatric Patients at Risk of Metabolic Disturbances.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026

Related Experiment Video

Updated: Apr 17, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.7K

Long-term plasma exchange in pediatric CIDP.

Marta Lucchetta1, Enrico Vidal2, Stefano Sartori2

  • 1Department of Neurosciences, University of Padova, Padova, Italy.

Journal of Clinical Apheresis
|February 10, 2015
PubMed
Summary

Therapeutic plasma exchange (TPE) offers long-term benefits for pediatric chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), even in patients with renal insufficiency. This case highlights TPE as a viable long-term treatment option.

Keywords:
CIDPpediatricplasma exchange

More Related Videos

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
05:57

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Published on: August 2, 2022

5.3K
Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid
10:42

Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid

Published on: April 11, 2019

10.8K

Related Experiment Videos

Last Updated: Apr 17, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.7K
Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
05:57

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Published on: August 2, 2022

5.3K
Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid
10:42

Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid

Published on: April 11, 2019

10.8K

Area of Science:

  • Neurology
  • Immunology
  • Nephrology

Background:

  • Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare autoimmune disorder affecting peripheral nerves.
  • Therapeutic plasma exchange (TPE) is typically reserved for short-term management due to limited long-term efficacy.
  • Pediatric CIDP management often involves other first-line therapies.

Observation:

  • A 16-year-old male with end-stage renal disease on hemodialysis developed CIDP.
  • The patient underwent TPE as a therapeutic option, facilitated by his existing hemodialysis regimen.
  • Nerve ultrasound and MRI were utilized to assess disease progression and treatment response.

Findings:

  • The patient experienced a dramatic and sustained long-term response to TPE therapy.
  • This contrasts with the generally observed short-term benefits of TPE in CIDP.
  • Imaging findings correlated with the clinical improvement.

Implications:

  • TPE may be a valuable long-term therapeutic strategy for select pediatric CIDP cases, particularly those with comorbidities like renal insufficiency.
  • This case challenges the conventional view of TPE's limited long-term utility in CIDP.
  • Further research into TPE's role in refractory or complex pediatric CIDP cases is warranted.